Cysteamine Bitartrate

CHEMBL1200577 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

227.2 g/mol

LogP

—

Phase

4

The bitartrate salt of cysteamine, used orally to treat nephropathic cystinosis by reducing intracellular cystine accumulation. The delayed-release bitartrate formulation improves tolerability compared to the immediate-release form.

Moleküler Ağırlık

227,2400 g/mol

TPSA

142,00 Å²

Terapötik Alanlar

Asthma Schizophrenia Non-Alcoholic Fatty Liver Disease Stroke Major Depressive Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

NCCS.O=C(O)[C@H](O)[C@@H](O)C(=O)O

InChI

InChI=1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2/t1-,2-;/m1./s1

Molecular Formula

C6H13NO6S

HBD / HBA

6 / 8

Döndürülebilir Bağlar

4

Ağır Atomlar

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

The bitartrate salt of cysteamine, used orally to treat nephropathic cystinosis by reducing intracellular cystine accumulation. The delayed-release bitartrate formulation improves tolerability compared to the immediate-release form.

Yes, Cysteamine Bitartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200577. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11958147. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Cysteamine Bitartrate PillFYI'da

Yapı

Hızlı Veriler

Formül: C6H13NO6S
Eş Anlamlılar: 2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.